ELISA testing market to reach $4.11B by 2030 at 6.2% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Forecasted Market Size Trajectory Of The Enzyme-Linked Immunosorbent Assay Testing Market From 2026 To 2030?
The enzyme-linked immunosorbent assay testing market has experienced significant expansion recently. Projections indicate it will increase from $3.04 billion in 2025 to $3.24 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.5%. Historically, this growth has been driven by several factors, including the extensive application of ELISA in diagnostic testing, the broader scope of biomedical research activities, the rising incidence of infectious and chronic ailments, the increasing dependence on immunoassays, and the establishment of standardized testing protocols.
The enzyme-linked immunosorbent assay testing market is anticipated to experience robust expansion in the coming years. It is projected to reach $4.12 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.2%. The growth during this forecast period is attributable to several factors, including the increasing integration of automated laboratory workflows, a surging demand for biomarker-based diagnostics, the broadening of ELISA applications within oncology and immunology, a heightened emphasis on early disease detection, and a rise in investments in clinical research infrastructure. Furthermore, key trends expected over the forecast horizon encompass a greater uptake of high-throughput ELISA platforms, an escalating need for multiplex immunoassays, the increasing incorporation of automated sample processing, an expansion in the utilization of ELISA within clinical research, and a strengthened emphasis on the sensitivity and accuracy of assays.
Access Your Free Sample Report For In-Depth Market Analysis:
What Key Factors Are Affecting The Enzyme-Linked Immunosorbent Assay Testing Market Demand?
The escalating occurrence of infectious disorders is projected to boost the growth of the enzyme-linked immunosorbent assay testing market in the upcoming period. These disorders are illnesses caused by pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, which can disseminate among individuals and affect various bodily systems. The rising prevalence of infectious conditions is linked to increased international travel and the development of antimicrobial resistance, complicating efforts in infection control. Enzyme-linked immunosorbent assay (ELISA) testing proves valuable for infectious disorders as it enables the precise identification and quantification of specific antigens or antibodies associated with an infection, thereby assisting in diagnosis, monitoring disease progression, and evaluating the effectiveness of treatments. For instance, in February 2024, data released by the World Health Organization, a Switzerland-based intergovernmental public health organization, indicated that the European Region documented a total of 58114 measles cases in 2023, a highly contagious viral disease, contrasting with 941 cases reported in 2022. Hence, the increasing incidence of infectious disorders is propelling the expansion of the enzyme-linked immunosorbent assay testing market.
Which Segment Classifications Are Used In The Enzyme-Linked Immunosorbent Assay Testing Market Segment Analysis?
The enzyme-linked immunosorbent assay testing market covered in this report is segmented –
1) By Type: Direct Enzyme-Linked Immunosorbent Assay (ELISA), Sandwich Enzyme-Linked Immunosorbent Assay (ELISA), Indirect Enzyme-Linked Immunosorbent Assay (ELISA), Multiple And Portable Enzyme-Linked Immunosorbent Assay (ELISA), Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
2) By Application: Immunology, Inflammation, Infectious Diseases, Cancer, Protein Quantitation, Other Applications
3) By End-User: Hospitals And Diagnostic Centers, Research Laboratories, Other End-Users
Subsegments:
1) By Direct Enzyme-Linked Immunosorbent Assay (ELISA): Single-Step Direct ELISA, Competitive Direct ELISA, Quantitative Direct ELISA, Qualitative Direct ELISA
2) By Sandwich Enzyme-Linked Immunosorbent Assay (ELISA): Two-Step Sandwich ELISA, One-Step Sandwich ELISA, Quantitative Sandwich ELISA, Qualitative Sandwich ELISA
3) By Indirect Enzyme-Linked Immunosorbent Assay (ELISA): Standard Indirect ELISA, Competitive Indirect ELISA, Quantitative Indirect ELISA, Qualitative Indirect ELISA
4) By Multiple And Portable Enzyme-Linked Immunosorbent Assay (ELISA): Multiplex ELISA (Multi-Analyte ELISA), Portable / Point-of-Care (POC) ELISA, Microfluidic-Based ELISA, Quantitative Portable ELISA, Qualitative Portable ELISA
5) By Competitive Enzyme-Linked Immunosorbent Assay (ELISA): Direct Competitive ELISA, Indirect Competitive ELISA, Quantitative Competitive ELISA, Qualitative Competitive ELISA
What Trends Are Influencing Changes In The Enzyme-Linked Immunosorbent Assay Testing Market?
Leading companies within the enzyme-linked immunosorbent assay testing market are focusing on expanding their product offerings through innovations, such as advanced enzyme-linked immunosorbent assay (ELISA) kits, to improve diagnostic accuracy and cater to various research and clinical needs. These novel Enzyme-Linked Immunosorbent Assay (ELISA) kits represent sophisticated versions of ELISA tests, providing enhanced accuracy, sensitivity, and usability for detecting and quantifying biomarkers. For instance, in February 2023, Charles River Laboratories, a US-based pharmaceutical company, launched a new enzyme-linked immunosorbent assay (ELISA) kit designed for the detection and quantitation of residual host cell proteins (HCP) in CHO-based biotherapeutics. This innovative kit incorporates avian immunoglobulin Y (IgY) antibodies, sourced from specific pathogen-free (SPF) chicken eggs, which ensures heightened sensitivity and specificity, with detection limits as low as 0.1 ng/mL and 90% antibody coverage. This introduction aims to enhance quality control in biopharmaceutical development, thereby guaranteeing the safety and efficacy of new therapies, while also providing clients with flexible usage options, either independently or with assistance from Charles River’s experts.
Which Firms Are Contributing To The Enzyme-Linked Immunosorbent Assay Testing Market Ecosystem?
Major companies operating in the enzyme-linked immunosorbent assay testing market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Tecan Group Ltd., GenScript Biotech Corporation, Promega Corporation, Abcam plc, R&D Systems Inc, Sino Biological Inc., OriGene Technologies Inc., RayBiotech Inc., Santa Cruz Biotechnology Inc., AnaSpec Inc., Biomatik, Arigo Biolaboratories Corp., MyBioSource Inc., Boster Biological Technology, Eagle Biosciences Inc., Enzo Life Sciences Inc., StressMarq Biosciences Inc., XpressBio
Get The Full Enzyme-Linked Immunosorbent Assay Testing Market Report:
Which Region Is The Leading Market For The Enzyme-Linked Immunosorbent Assay Testing Market?
North America was the largest region in the enzyme-linked immunosorbent assay testing market in 2025. The regions covered in the enzyme-linked immunosorbent assay testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Enzyme-Linked Immunosorbent Assay Testing Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Enzyme-Linked Immunosorbent Assay Testing Market 2026, By The Business Research Company
Bioanalytical Testing Services Market Report 2026
Noise Vibration Harshness Testing Market Report 2026
Cannabis Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/cannabis-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
